PL3413872T3 - Nieinwazyjna wkładkowa technologia podawania leków do oka - Google Patents
Nieinwazyjna wkładkowa technologia podawania leków do okaInfo
- Publication number
- PL3413872T3 PL3413872T3 PL17714012.6T PL17714012T PL3413872T3 PL 3413872 T3 PL3413872 T3 PL 3413872T3 PL 17714012 T PL17714012 T PL 17714012T PL 3413872 T3 PL3413872 T3 PL 3413872T3
- Authority
- PL
- Poland
- Prior art keywords
- drug delivery
- ocular drug
- delivery insert
- insert technology
- invasive ocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/02—Artificial eyes from organic plastic material
- B29D11/023—Implants for natural eyes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
- B29D11/00096—Production of contact lenses for delivering compositions, e.g. drugs to the eye
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
- B29K2067/04—Polyesters derived from hydroxycarboxylic acids
- B29K2067/046—PLA, i.e. polylactic acid or polylactide
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2071/00—Use of polyethers, e.g. PEEK, i.e. polyether-etherketone or PEK, i.e. polyetherketone or derivatives thereof, as moulding material
- B29K2071/02—Polyalkylene oxides, e.g. PEO, i.e. polyethylene oxide, or derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
- B29K2105/0035—Medical or pharmaceutical agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0085—Copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT109154A PT109154B (pt) | 2016-02-12 | 2016-02-12 | Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos |
PCT/IB2017/050731 WO2017137934A1 (en) | 2016-02-12 | 2017-02-10 | Non-invasive ocular drug delivery insert technology |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3413872T3 true PL3413872T3 (pl) | 2025-02-17 |
Family
ID=58428316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17714012.6T PL3413872T3 (pl) | 2016-02-12 | 2017-02-10 | Nieinwazyjna wkładkowa technologia podawania leków do oka |
Country Status (12)
Country | Link |
---|---|
US (1) | US11642311B2 (pl) |
EP (1) | EP3413872B1 (pl) |
JP (1) | JP7628675B2 (pl) |
AU (1) | AU2017217358B2 (pl) |
CA (1) | CA3013878C (pl) |
HR (1) | HRP20241683T1 (pl) |
PL (1) | PL3413872T3 (pl) |
PT (1) | PT109154B (pl) |
RS (1) | RS66340B1 (pl) |
RU (1) | RU2749426C2 (pl) |
SG (1) | SG11201806625WA (pl) |
WO (1) | WO2017137934A1 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3803866A4 (en) | 2018-05-24 | 2022-03-16 | Nureva Inc. | METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS |
SG11202005949UA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
BR112020023983A2 (pt) | 2018-05-24 | 2021-02-23 | Celanese Eva Performance Polymers Llc | dispositivo implantável para liberação prolongada de um composto de fármaco macromolecular |
GB2601922B (en) | 2019-06-27 | 2024-04-24 | Layerbio Inc | Ocular device drub delivery systems |
US11931454B2 (en) | 2019-09-18 | 2024-03-19 | Alcon Inc. | Wet-packed soft hydrogel ocular inserts |
CN113057794B (zh) * | 2019-12-31 | 2023-03-10 | 财团法人工业技术研究院 | 眼用药物输送装置及其制备方法 |
EP4138745A4 (en) * | 2020-04-20 | 2024-05-29 | Avisi Ltd. | OPHTHALMIC DEVICE |
MX2023002902A (es) * | 2020-09-14 | 2023-04-05 | Eyepoint Pharmaceuticals Inc | Inserto bioerosionable de administracion ocular de farmacos y metodo terapeutico. |
CN112618480B (zh) * | 2020-11-10 | 2022-07-12 | 南昌大学 | 一种眼部药物递送体系的制备方法 |
JP2023552599A (ja) * | 2020-12-11 | 2023-12-18 | エフ. ホフマン-ラ ロシュ アーゲー | 新規ポリマー及びその使用 |
WO2024180472A1 (en) | 2023-02-28 | 2024-09-06 | Alcon Inc. | Ocular inserts |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3993071A (en) * | 1971-09-09 | 1976-11-23 | Alza Corporation | Bioerodible ocular device |
US3826258A (en) * | 1972-02-07 | 1974-07-30 | S Abraham | Gradual release medicine carrier |
US4438123A (en) | 1980-03-04 | 1984-03-20 | Merck & Co., Inc. | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure |
US4713244A (en) | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
US4931279A (en) | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
US4668506A (en) | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
US5137728A (en) * | 1988-03-01 | 1992-08-11 | Bausch & Lomb Incorporated | Ophthalmic article |
RU2014813C1 (ru) * | 1992-07-03 | 1994-06-30 | Фирма "Токем" | Способ изготовления вкладыша для лечения химических ожогов глаз |
RU2100020C1 (ru) * | 1993-06-23 | 1997-12-27 | Лейрас Ой | Средство для местного лечения глазной гипертензии и глаукомы и способ его получения |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US6217896B1 (en) * | 1999-04-01 | 2001-04-17 | Uab Research Foundation | Conjunctival inserts for topical delivery of medication or lubrication |
US6468543B1 (en) | 1999-05-03 | 2002-10-22 | Zymogenetics, Inc. | Methods for promoting growth of bone using ZVEGF4 |
FR2795326B1 (fr) * | 1999-06-28 | 2001-08-31 | Adir | Composition pharmaceutique solide thermoformable a liberation controlee |
US6331313B1 (en) * | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
AU2141202A (en) * | 2000-12-05 | 2002-06-18 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
NZ540885A (en) | 2002-12-20 | 2009-02-28 | Chakshu Res Inc | Ophthalmic formulation for the prevention and treatment of ocular conditions |
US8685435B2 (en) * | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
US7799336B2 (en) * | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US7320690B2 (en) * | 2004-05-13 | 2008-01-22 | Biocoat Incorporated | IOL insertion device with lubricious coating |
WO2006002366A2 (en) * | 2004-06-24 | 2006-01-05 | Surmodics, Inc. | Biodegradable ocular devices, methods and systems |
JP5081413B2 (ja) * | 2005-07-29 | 2012-11-28 | 参天製薬株式会社 | 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム |
KR101464003B1 (ko) * | 2005-07-29 | 2014-11-20 | 산텐 세이야꾸 가부시키가이샤 | 고형 조성물을 이용한 후안부 조직으로의 비침습성 약물전달 시스템 |
US9693967B2 (en) * | 2005-09-07 | 2017-07-04 | Southwest Research Institute | Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates |
US8586556B2 (en) | 2006-11-03 | 2013-11-19 | Allergan, Inc. | Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules |
TR200708925A1 (tr) * | 2007-12-26 | 2009-07-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Kontrollü salım sağlayan flurbiprofen ve kas gevşetici kombinasyonları |
RU2565445C2 (ru) * | 2010-01-22 | 2015-10-20 | Аллерган, Инк. | Внутрикамерные имплантаты с пролонгированным высвобождением терапевтического агента |
KR101914119B1 (ko) * | 2010-03-16 | 2018-11-02 | 타이탄 파머슈티컬즈 인코퍼레이티드 | 약물 전달용 이종 이식가능 장치 |
CA2798084A1 (en) * | 2010-05-17 | 2011-11-24 | Aerie Pharmaceuticals, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
US8821457B2 (en) * | 2010-09-08 | 2014-09-02 | Johnson & Johnson Vision Care, Inc. | Punctal plug containing drug formulation |
US20120215184A1 (en) * | 2011-02-18 | 2012-08-23 | Valeant International (Barbados) Srl | Cylindrical ocular inserts |
-
2016
- 2016-02-12 PT PT109154A patent/PT109154B/pt active IP Right Grant
-
2017
- 2017-02-10 SG SG11201806625WA patent/SG11201806625WA/en unknown
- 2017-02-10 CA CA3013878A patent/CA3013878C/en active Active
- 2017-02-10 RS RS20241432A patent/RS66340B1/sr unknown
- 2017-02-10 JP JP2018541673A patent/JP7628675B2/ja active Active
- 2017-02-10 EP EP17714012.6A patent/EP3413872B1/en active Active
- 2017-02-10 US US16/077,493 patent/US11642311B2/en active Active
- 2017-02-10 HR HRP20241683TT patent/HRP20241683T1/hr unknown
- 2017-02-10 RU RU2018128943A patent/RU2749426C2/ru active
- 2017-02-10 WO PCT/IB2017/050731 patent/WO2017137934A1/en active Application Filing
- 2017-02-10 AU AU2017217358A patent/AU2017217358B2/en active Active
- 2017-02-10 PL PL17714012.6T patent/PL3413872T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
JP2019504855A (ja) | 2019-02-21 |
US20190046434A1 (en) | 2019-02-14 |
RU2018128943A3 (pl) | 2020-06-01 |
HRP20241683T1 (hr) | 2025-02-28 |
RS66340B1 (sr) | 2025-01-31 |
CA3013878A1 (en) | 2017-08-17 |
PT109154A (pt) | 2017-08-14 |
EP3413872A1 (en) | 2018-12-19 |
CA3013878C (en) | 2024-06-25 |
PT109154B (pt) | 2019-11-05 |
JP7628675B2 (ja) | 2025-02-12 |
US11642311B2 (en) | 2023-05-09 |
AU2017217358B2 (en) | 2022-09-29 |
SG11201806625WA (en) | 2018-09-27 |
AU2017217358A1 (en) | 2018-08-30 |
WO2017137934A1 (en) | 2017-08-17 |
EP3413872C0 (en) | 2024-10-02 |
RU2749426C2 (ru) | 2021-06-10 |
EP3413872B1 (en) | 2024-10-02 |
BR112018016301A2 (pt) | 2018-12-26 |
RU2018128943A (ru) | 2020-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3463228A4 (en) | INTRAOCULAR ADMINISTRATION OF MEDICINES | |
PL3413872T3 (pl) | Nieinwazyjna wkładkowa technologia podawania leków do oka | |
ZAA201800376S (en) | Drug delivery devices | |
EP3302265A4 (en) | Drug delivery capsule | |
GB201913962D0 (en) | Ophthalmic drug compositions | |
EP3265064A4 (en) | Drug delivery device | |
GB201612516D0 (en) | Medicament delivery device | |
IL262062A (en) | Implantable ophthalmic drug delivery devices | |
SMT202100310T1 (it) | Dispositivi per la deposizione di farmaci in vivo | |
EP3532131A4 (en) | PORTABLE DRUG DELIVERY DEVICE | |
GB201701935D0 (en) | Medicament delivery devices | |
PT3622986T (pt) | Dispositivo de aplicação de medicamento | |
EP3263155A4 (en) | Drug solution administering device | |
GB201619562D0 (en) | Medicament delivery device | |
GB2563875B (en) | Improvements in drug delivery | |
GB201807040D0 (en) | Drug delivery | |
HUE057487T2 (hu) | Gyógyszeradagoló rendszer | |
GB201712184D0 (en) | Medicament delivery device | |
GB201721832D0 (en) | Ocular drug delivery | |
GB201619556D0 (en) | Medicament delivery device | |
GB201607778D0 (en) | Drug delivery device | |
HK1206254A1 (en) | Stable liposomal formulations for ocular drug delivery | |
GB2570113B (en) | Ocular drug delivery system | |
GB201410507D0 (en) | Drug delivery enhancement agents | |
EP3151901A4 (en) | Intravascular catheter with drug delivery system |